Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone

Authors :: Gerald F. Watts
Shiva Ganjali
Peter E. Penson
Vanessa Bianconi
Amirhossein Sahebkar
Matteo Pirro
Maciej Banach
Source :: Metabolism
Publisher :: Elsevier

Subjects :: medicine.medical_specialty
2019-20 coronavirus outbreak
RM
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Endocrinology, Diabetes and Metabolism
NF-kB, Nuclear factor kappa-light-chain-enhancer of activated B cells
Coronary Artery Disease
MYD88, Myeloid differentiation primary response 88
Article
LDL, LOW-density lipoprotein
SARS-CoV, Severe acute respiratory syndrome coronavirus
Coronary artery disease
Endocrinology
CVD, Cardiovascular disease
Risk Factors
Internal medicine
ACE2, Angiotensin-converting enzyme 2
ARDS, Acute respiratory distress syndrome
Medicine
Humans
Cholesterol metabolism
Pandemics
Inflammation
COVID-19, Coronavirus disease 2019
business.industry
SARS-CoV-2
NF-kappa B
COVID-19
LDL - Low density lipoprotein
MERS-CoV, Middle East respiratory syndrome coronavirus
Virus Internalization
medicine.disease
Lipid Metabolism
ARDs - Acute respiratory distress syndrome
Acute cardiovascular disease
COVID-19 Drug Treatment
Cholesterol
Cardiovascular Diseases
Myeloid Differentiation Factor 88
Hydroxymethylglutaryl-CoA Reductase Inhibitors
business
TLR, Toll-like receptor
Signal Transduction

Tools